PMV Pharmaceuticals, Inc.
PMVP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001699382
No open-market purchases or sales by PMV Pharmaceuticals, Inc. insiders were filed in the last 90 days; 64 institutions reported holding it in 13F filings for Q2 2026, worth $45.9M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding PMV Pharmaceuticals, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 105 | 120 | +15 |
| Shares | 61.1M | 58.2M | −2.95M (−4.8%) |
| Value | $870.9M | $692.3M | −$178.7M (−20.5%) |
New holders (25)
Institutions that held PMV Pharmaceuticals, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (10)
Institutions that held PMV Pharmaceuticals, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Casdin Capital, LLC | 300,000 | $4.28M |
| Bank of Montreal | 158,368 | $2.17M |
| Canada Pension Plan Investment Board | 113,500 | $1.62M |
| SG Americas Securities, LLC | 64,830 | $924.0K |
| Simplex Trading, LLC | 48,757 | $694.0K |
| Virtu Financial LLC | 26,378 | $376.0K |
| Hershey Trust Co | 9,346 | $133.0K |
| Caption Management, LLC | 4,285 | $61.0K |
| Quantbot Technologies LP | 1,856 | $26.0K |
| Prospera Financial Services Inc | 136 | $2.00K |